Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Heidi Rehm, Geoffrey Ginsberg, Thomas Quertermous, Mark Yandell, and More

Premium

Omicia has appointed Heidi Rehm, Geoffrey Ginsberg, Thomas Quertermous, and Mark Yandell to its scientific advisory board. Rehm is director of the Laboratory for Molecular Medicine at Partners Healthcare Personalized Medicine and associate professor of pathology at Harvard Medical School. Ginsberg is director of genomic medicine at the Duke Institute for Genome Sciences & Policy, executive director of Duke's Center for Personalized Medicine and Precision, and a professor of medicine and biomedical engineering. Quertermous is the William G. Irwin professor of medicine and director of research for the division of cardiovascular medicine at Stanford University. Yandell is co-director of the University of Utah's USTAR Center for Genetic Discovery, a professor of human genetics, and a co-inventor of Omicia's VAAST and Phevor algorithms.


The UK's National Health Service has appointed John Burn to its board of directors as a non-executive director for four years beginning July 1. Burn is the chief medical officer of QuantuMDx and holds the NHS Endowed Chair in Clinical Genetics at Newcastle University.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.